Zoubkova H, Tomaskova A, Nohejlova K, Cerna M, Slamberova R
Front Neurosci. 2019; 13:771.
PMID: 31417344
PMC: 6686742.
DOI: 10.3389/fnins.2019.00771.
Bagley K, Badry D
Int J Environ Res Public Health. 2019; 16(11).
PMID: 31159237
PMC: 6603929.
DOI: 10.3390/ijerph16111936.
Holubova A, Lukaskova I, Tomasova N, Suhajdova M, Slamberova R
Front Behav Neurosci. 2018; 12:176.
PMID: 30174595
PMC: 6107702.
DOI: 10.3389/fnbeh.2018.00176.
Baei F, Rajabzadeh A, Bagheri J, Jalayeri Z, Ebrahimzadeh-Bideskan A
Metab Brain Dis. 2017; 32(4):991-1002.
PMID: 28243847
DOI: 10.1007/s11011-017-9973-8.
Chakraborty A, Anstice N, Jacobs R, Lagasse L, Lester B, Wouldes T
Sci Rep. 2015; 5:16921.
PMID: 26581958
PMC: 4652269.
DOI: 10.1038/srep16921.
Effect of prenatal methamphetamine administration during gestational days on mice.
Khoradmehr A, Danafar A, Halvaei I, Golzadeh J, Hosseini M, Mirjalili T
Iran J Reprod Med. 2015; 13(1):41-8.
PMID: 25653675
PMC: 4306984.
Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.
Wouldes T, Lagasse L, Huestis M, DellaGrotta S, Dansereau L, Lester B
Neurotoxicol Teratol. 2014; 42:77-84.
PMID: 24566524
PMC: 3997367.
DOI: 10.1016/j.ntt.2014.02.004.
Structural brain changes in prenatal methamphetamine-exposed children.
Roos A, Jones G, Howells F, Stein D, Donald K
Metab Brain Dis. 2014; 29(2):341-9.
PMID: 24553878
DOI: 10.1007/s11011-014-9500-0.
Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.
Abar B, Lagasse L, Wouldes T, Derauf C, Newman E, Shah R
Prev Sci. 2013; 15(5):767-76.
PMID: 23943149
PMC: 3947752.
DOI: 10.1007/s11121-013-0431-5.
Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.
Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L
Am J Orthopsychiatry. 2013; 83(1):64-72.
PMID: 23330624
PMC: 3721329.
DOI: 10.1111/ajop.12007.
Auditory evoked arousal responses of 3-month-old infants exposed to methamphetamine in utero: a nap study.
Galland B, Mitchell E, Thompson J, Wouldes T
Acta Paediatr. 2012; 102(4):424-30.
PMID: 23253105
PMC: 5341078.
DOI: 10.1111/apa.12136.
Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition.
Abar B, Lagasse L, Derauf C, Newman E, Shah R, Smith L
Psychol Addict Behav. 2012; 27(3):662-73.
PMID: 23067308
PMC: 3842232.
DOI: 10.1037/a0030157.
Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States.
Wu M, Lagasse L, Wouldes T, Arria A, Wilcox T, Derauf C
Matern Child Health J. 2012; 17(3):566-75.
PMID: 22588827
PMC: 3717345.
DOI: 10.1007/s10995-012-1033-8.
Understanding the diverse needs of children whose parents abuse substances.
Solis J, Shadur J, Burns A, Hussong A
Curr Drug Abuse Rev. 2012; 5(2):135-47.
PMID: 22455509
PMC: 3676900.
DOI: 10.2174/1874473711205020135.
Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.
Lagasse L, Wouldes T, Newman E, Smith L, Shah R, Derauf C
Neurotoxicol Teratol. 2010; 33(1):166-75.
PMID: 20615464
PMC: 2974956.
DOI: 10.1016/j.ntt.2010.06.009.
Children of addicted women.
Lester B, Lagasse L
J Addict Dis. 2010; 29(2):259-76.
PMID: 20407981
PMC: 4451952.
DOI: 10.1080/10550881003684921.
Fetal effects of psychoactive drugs.
Salisbury A, Ponder K, Padbury J, Lester B
Clin Perinatol. 2009; 36(3):595-619.
PMID: 19732616
PMC: 2767264.
DOI: 10.1016/j.clp.2009.06.002.
Methamphetamine detection in maternal and neonatal hair: implications for fetal safety.
Garcia-Bournissen F, Rokach B, Karaskov T, Koren G
Arch Dis Child Fetal Neonatal Ed. 2006; 92(5):F351-5.
PMID: 17077112
PMC: 2675355.
DOI: 10.1136/adc.2006.100156.
